Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and Novo Nordisk announced the establishment of an international postdoctoral fellowship programme to support research within the fields of diabetes, metabolism and endocrinology. A total of 12 postdoctoral fellowships will be awarded, each for a 3 year period. The fellows will be hosted by Oxford University and funded by Novo Nordisk. The goal of the new programme is to support the development of a new generation of research leaders while further developing scientific excellence within diabetes.

Logo of Novo Nordisk (University of Oxford).

The programme will be coordinated through the Radcliffe Department of Medicine (RDM). The first four fellows in the programme will start in the autumn of 2014. Full details on the programme will be available shortly on the RDM website. Any enquiries should be directed to Dr Ruth McCaffrey.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.

Iron integral to the development of life on Earth – and the possibility of life on other planets

A collaboration between researchers at the MRC WIMM/RDM and Department of Earth Sciences uncovers the importance of iron for the development of complex life on Earth.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the Patel Group sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.